Video

Dr. Siegel on Induction Therapy for Head and Neck Cancer

Robert Siegel, MD, chair, professor of medicine, director, Division of Hematology/Oncology, George Washington University, discusses induction therapy for head and neck cancer.

Robert Siegel, MD, chair, professor of medicine, director, Division of Hematology/Oncology, George Washington University, discusses induction therapy for head and neck cancer.

In head and neck cancer, when physicians are using induction therapy there have been 3 drugs that have been used, states Siegel. These are docetaxel, cisplatin, and 5-flourouracil (5-FU). According to Siegel, 5-FU adds more toxicity than efficacy.

Related Videos
Michael R. Bishop, MD
Lori A Leslie, MD
Andrew Ip, MD
Mansi R. Shah, MD
Elizabeth Buchbinder, MD
Benjamin Garmezy, MD, assistant director, Genitourinary Research, Sarah Cannon Research Institute
Alec Watson, MD
Sagar D. Sardesai, MBBS
Ashkan Emadi, MD, PhD
Matthew J. Baker, PhD